Keyword: US Merck

News

Merck & Co Files for Oral Covid Antiviral EUA

12.10.2021 -

US pharma giant Merck & Co has applied to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its oral antiviral drug molnupiravir...

News

US Merck to Make Covid Vaccine for J&J

03.03.2021 -

Another “Big Pharma” company with a stalled candidate of its own is stepping in to help boost national or regional Covid-19 vaccine supply. US president Joe Biden was due...

News

US Merck Divests Moderna Holding

09.12.2020 -

US pharma giant Merck has divested its direct holding in Moderna just as the US biotech is on the cusp of receiving an emergency use authorization (EUA) for its mRNA...

News

Keytruda Wins two new Cancer Approvals

12.06.2019 - Keytruda, the multi-indication oncology drug manufactured by US Merck & Co, has won approval from the Food and Drug Administration (FDA) for both monotherapy and combination...

News

Merck & Co. to Acquire Peloton for $2.2 Billion

23.05.2019 - US drugmaker Merck & Co. is to buy Peloton Therapeutics in a deal that could be worth as much as $2.2 billion to the clinical-stage biopharma. The acquisition would give Merck...

News

FDA Approves US Merck-Pfizer Cancer Treatment

30.04.2019 - Two months earlier than expected, the US Food and Drug Administration (FDA) has greenlighted the use of Merck & Co’s multi-indication cancer treatment Keytruda in combination with...

News

US Merck Beefs up Animal Health With Antelliq Buy

19.12.2018 - Merck & Co has agreed to acquire French animal health company Antelliq for a cash payment of about €2.1 billion. Upon completion of the deal, expected in the second quarter of 2019...

News

Pfizer Takes Medivation for $14 billion

22.08.2016 - Pfizer has won the race for biotech firm Medivation. The US drugs giant has agreed to pay about $14 billion in a move that adds leading prostate cancer drug Xtandi to its portfolio...